JP2004536824A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536824A5
JP2004536824A5 JP2003506430A JP2003506430A JP2004536824A5 JP 2004536824 A5 JP2004536824 A5 JP 2004536824A5 JP 2003506430 A JP2003506430 A JP 2003506430A JP 2003506430 A JP2003506430 A JP 2003506430A JP 2004536824 A5 JP2004536824 A5 JP 2004536824A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
seq
chimeric monoclonal
acid sequence
organism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003506430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536824A (ja
Filing date
Publication date
Priority claimed from US09/881,823 external-priority patent/US20020068066A1/en
Application filed filed Critical
Publication of JP2004536824A publication Critical patent/JP2004536824A/ja
Publication of JP2004536824A5 publication Critical patent/JP2004536824A5/ja
Pending legal-status Critical Current

Links

JP2003506430A 2001-06-15 2002-06-11 Ｓ．ｍｕｔａｎｓに対するヒト化モノクローナル抗体を作製するためのＤＮＡ分子および組換えＤＮＡ分子 Pending JP2004536824A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/881,823 US20020068066A1 (en) 1999-08-20 2001-06-15 Method for the treatment and prevention of dental caries
PCT/US2002/018692 WO2002102975A2 (en) 2001-06-15 2002-06-11 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans

Publications (2)

Publication Number Publication Date
JP2004536824A JP2004536824A (ja) 2004-12-09
JP2004536824A5 true JP2004536824A5 (enExample) 2005-09-22

Family

ID=25379292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003506430A Pending JP2004536824A (ja) 2001-06-15 2002-06-11 Ｓ．ｍｕｔａｎｓに対するヒト化モノクローナル抗体を作製するためのＤＮＡ分子および組換えＤＮＡ分子

Country Status (6)

Country Link
US (1) US20020068066A1 (enExample)
EP (1) EP1434799A4 (enExample)
JP (1) JP2004536824A (enExample)
AU (1) AU2002318342A2 (enExample)
CA (1) CA2448506A1 (enExample)
WO (1) WO2002102975A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
CA2661634C (en) 2006-09-06 2017-03-28 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
CN101622271B (zh) 2007-01-16 2014-08-27 加利福尼亚大学董事会 抗微生物肽
AU2014203172B2 (en) * 2010-02-24 2016-03-10 Immunogen, Inc. Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
CN105777907B (zh) 2010-02-24 2020-03-17 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
CL2011003002A1 (es) * 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.
US20160082129A1 (en) * 2014-09-24 2016-03-24 Aerpio Therapeutics, Inc. VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy Vector
SG10201912556VA (en) * 2016-07-20 2020-02-27 Aerpio Therapeutics Inc HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-ß)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
EP0590058B1 (en) * 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
JP4731687B2 (ja) * 1998-08-21 2011-07-27 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア ストレプトコッカス・ミュータンスに特異的なモノクロナール抗体、およびその使用
AU2000270698A1 (en) * 2000-08-24 2002-03-04 Regents Of The Universtiy Of California Immunologic method for the prevention of dental caries

Similar Documents

Publication Publication Date Title
JP2022105178A (ja) 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症を治療および予防するための組成物および方法
RU2757813C2 (ru) Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение
JP2919071B2 (ja) 癌および感染症にたいするワクチン
CN111683966B (zh) 与cd22结合的重链抗体
TWI843799B (zh) 抗pd-1抗體、其抗原結合片段及醫藥用途
CN104640878B (zh) 交叉反应的金黄色葡萄球菌抗体
JP2022031635A5 (enExample)
US20130267688A1 (en) Novel antibody structures derived from human germline sequences
WO2019091449A1 (zh) Cd96抗体、其抗原结合片段及医药用途
JP2022533538A5 (enExample)
RU2009128064A (ru) Антитела к cd44
EA200301098A1 (ru) Ассоциированные с ганглиозидами рекомбинантные антитела и их применение в диагностике и лечении опухолей
KR20200012920A (ko) 항-cd40 항체, 이의 항원 결합 단편 및 이의 의학적 용도
CN112513088A (zh) 抗ox40抗体、其抗原结合片段及其医药用途
WO2022105914A1 (zh) Cd70抗体及其应用
JP2024518844A5 (enExample)
CN109867723B (zh) 抗人il6单克隆抗体及其制备方法和用途
CN114829395A (zh) 抗angptl3抗体及其应用
JP2009524428A5 (enExample)
CZ20013673A3 (cs) Anti-idiotypová protilátka k protilátce inhibující vazbu imunglobulínu E na jeho receptor s vysokou afinitou a farmaceutický přípravek obsahující takovou protilátku
JP2018509147A (ja) 抗スクレロスチン抗体、その抗原結合フラグメントおよびその医薬用途
JP2003521219A5 (enExample)
KR20120016086A (ko) 슈도모나스 애루지노사 혈청형 ｉａｔｓ ０１의 지질다당류(ｌｐｓ) 특이적 인간 단일클론 항체
CA2525657A1 (en) Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
US20240059764A1 (en) ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF